Viewing Study NCT00246402


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-03-05 @ 7:57 AM
Study NCT ID: NCT00246402
Status: COMPLETED
Last Update Posted: 2014-05-15
First Post: 2005-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 337
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Colleen Hadigan, MD MPH
Old Organization: Harvard Medical School, Massachusetts General Hospital

Collaborators